0001654954-21-010887.txt : 20211007
0001654954-21-010887.hdr.sgml : 20211007
20211007144717
ACCESSION NUMBER: 0001654954-21-010887
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201116
FILED AS OF DATE: 20211007
DATE AS OF CHANGE: 20211007
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wendel Bruce
CENTRAL INDEX KEY: 0001364846
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40023
FILM NUMBER: 211312193
MAIL ADDRESS:
STREET 1: 70 ELEVEN O'CLOCK ROAD
CITY: WESTON
STATE: CT
ZIP: 06883
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GT Biopharma, Inc.
CENTRAL INDEX KEY: 0000109657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 941620407
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9350 WILSHIRE BLVD.
STREET 2: SUITE 203
CITY: BEVERLY HILLS
STATE: CA
ZIP: 90212
BUSINESS PHONE: (800) 304-9888
MAIL ADDRESS:
STREET 1: 9350 WILSHIRE BLVD.
STREET 2: SUITE 203
CITY: BEVERLY HILLS
STATE: CA
ZIP: 90212
FORMER COMPANY:
FORMER CONFORMED NAME: OXIS INTERNATIONAL INC
DATE OF NAME CHANGE: 19940916
FORMER COMPANY:
FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/
DATE OF NAME CHANGE: 19850312
4
1
section16.xml
FORM 4
X0306
4
2020-11-16
0000109657
GT Biopharma, Inc.
GTBP
0001364846
Wendel Bruce
C/O GT BIOPHARMA, INC.
9350 WILSHIRE BLVD. STE. 203
BEVERLY HILLS
CA
900212
true
Common Stock
2020-11-16
4
P
false
3268
3.14
A
3268
D
Common Stock
2020-12-22
4
P
false
1374
8.87
A
4642
D
Common Stock
2020-12-22
4
P
false
441
8.73
A
5083
D
Common Stock
2021-02-16
4
A
false
347572
0.00
A
352655
D
Option to purchase Common Stock
6.33
2021-02-16
4
A
false
50000
0.00
A
2031-02-15
Common Stock
50000
50000
D
Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on November 11 2020, 2021 and 2022.
1/3rd of the shares vest on February 16, 2021, 2022, and 2023.
Bruce Wendel
2021-10-06